Avacta Life Sciences Ltd | ClinicalTrials HQ

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cervical adenocarcinoma, cervical adenosquamous carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, gastric adenocarcinoma, intestinal disorder, lung disorder, lung neoplasm, neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma, vulvar adenocarcinoma	Recruiting	Phase 1	2026-10-05		NCT07454642
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, carcinoma, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, mouth disorder, neoplasm, ovarian cancer, ovarian carcinoma, ovarian disorder, salivary gland cancer, salivary gland disorder, sarcoma, skin disorder, transitional cell carcinoma, tumor of salivary gland, urothelial carcinoma	Active, not recruiting	Phase 1	2026-10-02		NCT04969835